Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9 USD | +5.63% |
|
+14.36% | +6.76% |
06-24 | Replimune Group, Inc.(NasdaqGS:REPL) dropped from S&P Biotechnology Select Industry Index | CI |
06-13 | Replimune Group Signs $100 Million PIPE Deal with Institutional Investors | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.76% | 523M | |
+38.65% | 39.1B | |
-8.62% | 38.76B | |
+26.95% | 31.24B | |
+10.74% | 25.9B | |
-13.50% | 25.8B | |
+44.87% | 14.06B | |
+34.36% | 13.12B | |
-7.14% | 11.32B | |
-12.61% | 10.68B |
- Stock Market
- Equities
- REPL Stock
- News Replimune Group, Inc.
- BMO Capital Adjusts Replimune Group's Price Target to $40 From $30, Keeps Outperform Rating